Slow Wound Healing: Drugs That Cause It and Medications That Treat It

At a glance

• Common drivers / poor circulation, diabetes, infection, pressure, smoking, malnutrition, and some medicines
• Medication rule / medication changes require the prescriber who manages the underlying condition
• Proven approach / diagnose the cause, control infection and pressure, restore perfusion, and use appropriate local wound care
• Urgent signs / spreading redness, fever, black tissue, severe pain, foul drainage, or a cold/pale limb

Why Wounds Heal Slowly

Repair requires adequate oxygen delivery, inflammation that is neither absent nor excessive, new tissue formation, and protection from repeated trauma. A wound can appear “medication related” when the real driver is arterial disease, venous disease, pressure, high glucose, neuropathy, infection, or inadequate debridement. Clinicians begin with the wound’s location, duration, drainage, pain, surrounding skin, pulses, sensation, glucose control, nutrition, and medication list.

The Wound Healing Society guidance emphasizes cause-directed care rather than a single drug fix. For example, a heel pressure injury, a venous leg ulcer, and a diabetic foot ulcer have different priorities.

Medicines That May Matter

Systemic corticosteroids can impair phases of tissue repair, especially with longer courses or higher exposure. Immunosuppressive and anticancer regimens may raise infection risk or affect cell growth. Some targeted cancer therapies have specific perioperative instructions because of bleeding or wound-healing concerns. Nonsteroidal anti-inflammatory drugs have more uncertain and context-dependent effects; animal data and certain surgical settings do not create a universal rule to avoid them for every wound.

The safe response is coordination, not abrupt discontinuation. Stopping steroids can cause adrenal crisis; stopping transplant medicines can threaten a graft; and holding cancer treatment can change cancer outcomes. The surgeon, oncologist, transplant team, rheumatologist, or prescribing clinician should decide whether timing or an alternative is appropriate.

How Clinicians Separate a Drug Effect From a Treatable Cause

The medication review is one part of a wound assessment, not a shortcut around it. A useful visit identifies the wound type and then asks whether there is inadequate blood flow, pressure or repetitive trauma, infection, high glucose, edema, neuropathy, or a nutrition barrier that can be corrected. A diabetic foot ulcer with reduced sensation needs a different plan from a lower-leg ulcer with edema or a postoperative incision that has separated. A pulse and sensation examination, and sometimes vascular testing or imaging, can help determine whether compression, off-loading, debridement, or referral for revascularization is the priority.

Medication questions should be concrete: When did the wound start relative to the medicine? Is the medicine essential? Is there a planned procedure? Is the person also using nicotine, over-the-counter anti-inflammatory medicines, supplements, or another drug that changes bleeding or infection risk? The answer may be to continue the medicine while treating the wound driver, to coordinate a temporary perioperative plan, or to use no medication change at all. It should not be an unsupervised attempt to taper a steroid or pause a disease-modifying therapy.

Antibiotics are also not a general wound-healing treatment. They are selected when a clinician finds a clinical infection, ideally with attention to the likely site and severity; they do not replace drainage, pressure relief, removal of nonviable tissue when indicated, or restoration of blood flow. The IWGDF/IDSA infection guideline and IWGDF 2023 wound-healing guideline place standard care and cause-specific management before add-on therapies for diabetes-related foot ulcers. This distinction is important when evaluating marketing claims for a topical product, peptide, or supplement.

Treatments With an Established Role

Treatment is selected for a defined wound type. Compression is central for many venous ulcers when arterial circulation is adequate. Off-loading is central for plantar diabetic foot ulcers. Revascularization may be essential when arterial disease limits blood flow. Debridement, moisture balance, and infection management are not interchangeable with supplements or “healing peptides.”

Becaplermin gel has a narrow FDA-approved indication: certain lower-extremity diabetic ulcers with adequate blood supply, used alongside good ulcer care. It is not a general treatment for every slow-healing wound. Its current prescribing information includes important use limitations and should guide selection. The DailyMed label is more reliable for its indication than a general wound-healing list.

Nutrition and Supplements

Protein-energy malnutrition, iron deficiency, and micronutrient deficiency can impair repair, but routine high-dose supplements are not a substitute for assessment. Nutrition support should address identified deficits, adequate calories and protein, swallowing ability, renal disease, and food access. Excess zinc, vitamin A, or other supplements can also cause harm or interact with medicines.

If a person has reduced appetite, unintended weight loss, malabsorption, kidney disease, or a large chronic wound, a registered dietitian and clinical team can tailor the plan. This is more useful than assuming that one supplement will correct every type of delayed healing.

When to Seek Care Quickly

Same-day evaluation is appropriate for spreading redness, fever, pus, increasing pain, new numbness, black or gray tissue, a wound on a diabetic foot, or reduced circulation signs such as a cold or pale foot. Contact the surgical team promptly for separation of an incision, new drainage, or worsening pain after an operation.

Bottom Line

Some medicines can contribute to delayed repair, but the cause is usually broader than a medication list. The highest-value next step is a wound and circulation assessment with the clinicians who prescribe any critical medicines. Do not replace cause-directed wound care with unsupported products or self-directed medication changes.

References

1. Wound Healing Society. Chronic wound treatment guidance. Wound Repair and Regeneration
2. DailyMed. Regranex (becaplermin) prescribing information. Current label
3. Centers for Disease Control and Prevention. Your feet and diabetes. CDC guidance
4. International Working Group on the Diabetic Foot. 2023 wound-healing interventions guideline. IWGDF guideline
5. Senneville E, et al. IWGDF/IDSA Guidelines on the Diagnosis and Treatment of Diabetes-related Foot Infections (IWGDF/IDSA 2023). PubMed
6. Chen P, et al. Guidelines on interventions to enhance healing of foot ulcers in people with diabetes (IWGDF 2023 update). PubMed